Search

everythinglearnresearchcommunity

for

Search:↓

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Lower irisin levels in the blood may indicate more severe acne.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Obese women with PCOS are more likely to have fatty liver disease.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.